Biblio

Export 1455 results:
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
S. Hoon Choi, Kim, Y. Hye, Hebisch, M., Sliwinski, C., Lee, S., D'Avanzo, C., Chen, H., Hooli, B., Asselin, C., Muffat, J., Klee, J. B., Zhang, C., Wainger, B. J., Peitz, M., Kovacs, D. M., Woolf, C. J., Wagner, S. L., Tanzi, R. E., and Kim, D. Yeon, A three-dimensional human neural cell culture model of Alzheimer's disease., Nature, vol. 515, no. 7526, pp. 274-8, 2014.
S. Hoon Choi, Kim, Y. Hye, Hebisch, M., Sliwinski, C., Lee, S., D'Avanzo, C., Chen, H., Hooli, B., Asselin, C., Muffat, J., Klee, J. B., Zhang, C., Wainger, B. J., Peitz, M., Kovacs, D. M., Woolf, C. J., Wagner, S. L., Tanzi, R. E., and Kim, D. Yeon, A three-dimensional human neural cell culture model of Alzheimer's disease., Nature, vol. 515, no. 7526, pp. 274-8, 2014.
R. Kandimalla and P Reddy, H., Therapeutics of Neurotransmitters in Alzheimer's Disease., J Alzheimers Dis, vol. 57, no. 4, pp. 1049-1069, 2017.
V. Shukla, Seo, J., Binukumar, B. K., Amin, N. D., Reddy, P., Grant, P., Kuntz, S., Kesavapany, S., Steiner, J., Mishra, S. K., Tsai, L. - H., and Pant, H. C., TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice., J Alzheimers Dis, vol. 56, no. 1, pp. 335-349, 2017.
V. Shukla, Seo, J., Binukumar, B. K., Amin, N. D., Reddy, P., Grant, P., Kuntz, S., Kesavapany, S., Steiner, J., Mishra, S. K., Tsai, L. - H., and Pant, H. C., TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice., J Alzheimers Dis, vol. 56, no. 1, pp. 335-349, 2017.
G. W. Rebok, Ball, K., Guey, L. T., Jones, R. N., Kim, H. - Y., King, J. W., Marsiske, M., Morris, J. N., Tennstedt, S. L., Unverzagt, F. W., and Willis, S. L., Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults., J Am Geriatr Soc, vol. 62, no. 1, pp. 16-24, 2014.
G. W. Rebok, Ball, K., Guey, L. T., Jones, R. N., Kim, H. - Y., King, J. W., Marsiske, M., Morris, J. N., Tennstedt, S. L., Unverzagt, F. W., and Willis, S. L., Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults., J Am Geriatr Soc, vol. 62, no. 1, pp. 16-24, 2014.
K. Planeta Kepp, Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease., J Alzheimers Dis, vol. 55, no. 2, pp. 447-457, 2017.
M. Bilgel, Koscik, R. L., An, Y., Prince, J. L., Resnick, S. M., Johnson, S. C., and Jedynak, B. M., Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies., J Alzheimers Dis, vol. 59, no. 4, pp. 1335-1347, 2017.
K. N. H. Nudelman, Lin, J., Lane, K. A., Nho, K., Kim, S., Faber, K. M., Risacher, S. L., Foroud, T. M., Gao, S., Davis, J. W., Weiner, M. W., and Saykin, A. J., Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort., J Alzheimers Dis, vol. 71, no. 1, pp. 33-43, 2019.
E. Z. Huie, Escudero, A., Saito, N., Harvey, D., Le Nguyen, M. -, Lucot, K. L., LaGrande, J., Mungas, D., DeCarli, C., Lamar, M., Schneider, J. A., Kapasi, A., Rissman, R. A., Teich, A. F., and Dugger, B. N., TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups., J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.
A. Sahoo, Bejanin, A., Murray, M. E., Tosakulwong, N., Weigand, S. D., Serie, A. M., Senjem, M. L., Machulda, M. M., Parisi, J. E., Boeve, B. F., Knopman, D. S., Petersen, R. C., Dickson, D. W., Whitwell, J. L., and Josephs, K. A., TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia., J Alzheimers Dis, vol. 64, no. 4, pp. 1227-1233, 2018.
B. H Kuiperij, Versleijen, A. A. M., Beenes, M., Verwey, N. A., Benussi, L., Paterlini, A., Binetti, G., Teunissen, C. E., Raaphorst, J., Schelhaas, H. J., Küsters, B., Pijnenburg, Y. A. L., Ghidoni, R., and Verbeek, M. M., Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study., J Alzheimers Dis, vol. 55, no. 2, pp. 585-595, 2017.
B. H Kuiperij, Versleijen, A. A. M., Beenes, M., Verwey, N. A., Benussi, L., Paterlini, A., Binetti, G., Teunissen, C. E., Raaphorst, J., Schelhaas, H. J., Küsters, B., Pijnenburg, Y. A. L., Ghidoni, R., and Verbeek, M. M., Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study., J Alzheimers Dis, vol. 55, no. 2, pp. 585-595, 2017.
J. P. Quinn, Corbett, N. J., Kellett, K. A. B., and Hooper, N. M., Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers., J Alzheimers Dis, vol. 63, no. 1, pp. 13-33, 2018.
W. A. Banks, Kovac, A., Majerova, P., Bullock, K. M., Shi, M., and Zhang, J., Tau Proteins Cross the Blood-Brain Barrier., J Alzheimers Dis, vol. 55, no. 1, pp. 411-419, 2017.
M. Kolarova, Sengupta, U., Bartos, A., Ricny, J., and Kayed, R., Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged Controls., J Alzheimers Dis, vol. 58, no. 2, pp. 471-478, 2017.
M. Kolarova, Sengupta, U., Bartos, A., Ricny, J., and Kayed, R., Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged Controls., J Alzheimers Dis, vol. 58, no. 2, pp. 471-478, 2017.
A. N. Nilson, English, K. C., Gerson, J. E., T Whittle, B., C Crain, N., Xue, J., Sengupta, U., Castillo-Carranza, D. L., Zhang, W., Gupta, P., and Kayed, R., Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases., J Alzheimers Dis, vol. 55, no. 3, pp. 1083-1099, 2017.
C. Hyoung Lyoo, Cho, H., Choi, J. Yong, Hwang, M. Song, Hong, S. Kyoon, Kim, Y. Joong, Ryu, Y. Hoon, and Lee, M. Sik, Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis., J Alzheimers Dis, vol. 51, no. 3, pp. 671-5, 2016.
E. L. Boespflug, Simon, M. J., Leonard, E., Grafe, M., Woltjer, R., Silbert, L. C., Kaye, J. A., and Iliff, J. J., Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer's Disease., J Alzheimers Dis, vol. 66, no. 4, pp. 1587-1597, 2018.
M. Buciuc, Tosakulwong, N., Machulda, M. M., Whitwell, J. L., Weigand, S. D., Murray, M. E., R Reichard, R., Parisi, J. E., Dickson, D. W., Boeve, B. F., Knopman, D. S., Petersen, R. C., and Josephs, K. A., TAR DNA-Binding Protein 43 Is Associated with Rate of Memory and Functional and Global Cognitive Decline in the Decade Prior to Death., J Alzheimers Dis, vol. 80, no. 2, pp. 683-693, 2021.
J. Tao, Liu, J., Liu, W., Huang, J., Xue, X., Chen, X., Wu, J., Zheng, G., Chen, B., Li, M., Sun, S., Jorgenson, K., Lang, C., Hu, K., Chen, S., Chen, L., and Kong, J., Tai Chi Chuan and Baduanjin Increase Grey Matter Volume in Older Adults: A Brain Imaging Study., J Alzheimers Dis, vol. 60, no. 2, pp. 389-400, 2017.

Pages